Ion Beam Applications SA (IOBCF)

Market Cap	426.57M +2.7%
Revenue (ttm)	728.19M +24.5%
Net Income	14.91M +37.3%
EPS	0.50 +37.0%
Shares Out	n/a
PE Ratio	28.61
Forward PE	15.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	546
Open	15.00
Previous Close	15.90
Day's Range	15.00 - 15.00
52-Week Range	10.15 - 19.00
Beta	1.20
RSI	46.43
Earnings Date	Mar 27, 2026

About Ion Beam Applications

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production o...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,100
• Stock Exchange: OTCMKTS
• Ticker Symbol: IOBCF

Financial Performance

In 2025, Ion Beam Applications's revenue was 620.20 million, an increase of 24.50% compared to the previous year's 498.16 million. Earnings were 12.70 million, an increase of 37.25%.

Financial numbers in EUR